Pomerantz Files Class Action Against Hims & Hers Health
A securities class action lawsuit targets Hims & Hers Health as investors face an upcoming filing deadline.
Pomerantz LLP has filed a class action lawsuit against Hims & Hers Health, Inc., the telehealth company traded on the New York Stock Exchange under the ticker HIMS, the firm announced September 24, 2026. Investors who suffered losses on their HIMS holdings are being urged to take note of approaching legal deadlines.
The New York-based law firm is directing affected shareholders to contact attorney Danielle Peyton for more information on the case and to determine eligibility to participate. Investors can reach the firm by email at newaction@pomlaw.com or by phone at 646-581-9980.
Read more Aberdeen Intermediate Income Fund Plans 1-for-6 Reverse Split →
Class action securities lawsuits of this type typically allege that a company or its executives made materially false or misleading statements that artificially affected the stock price, causing losses for shareholders who bought shares during the relevant period. The source does not detail the specific allegations underlying this filing against Hims & Hers.
Hims & Hers Health operates as a consumer-focused telehealth platform offering prescription and wellness products. The company has drawn significant investor attention in recent years amid the rapid growth of online healthcare services. Securities class actions can result in settlements or judgments that return funds to qualifying shareholders, though outcomes vary widely.
Investors with potential claims are advised to act promptly given the deadline-sensitive nature of securities litigation. Continue reading at All Financial Services & Investing.
